Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Carbopol is a polyanionic carbomer used in man for topical application and drug delivery purposes. However parenteral administration of Carbopol in animal models results in systemic adjuvant activity including strong pro-inflammatory type-1 T-cell (Th1) polarization. Here we investigated potential pathways of immune activation by Carbopol by comparison with other well-characterized adjuvants. Carbopol administration triggered rapid and robust leukocyte recruitment, pro-inflammatory cytokine secretion and antigen capture largely by inflammatory monocytes. The induction of antigen specific Th1 cells by Carbopol was found to occur via a non-canonical pathway, independent of MyD88/TRIF signaling and in the absence of pattern-recognition-receptor (PRR) activation typically associated with Th1/Ig2a induction. Using multispectral fluorescence imaging (Imagestream) and electron microscopy we demonstrated that phagocytic uptake of Carbopol particles followed by entry into the phagosomal/lysosomal pathway elicited conformational changes to the polymer and reactive oxygen species (ROS) production. We therefore conclude that Carbopol may mediate its adjuvant activity via novel mechanisms of antigen presenting cell activation and Th1 induction, leading to enhanced IgG2a responses independent of microbial pattern recognition.

Original publication

DOI

10.1016/j.vaccine.2016.03.025

Type

Journal article

Journal

Vaccine

Publication Date

27/04/2016

Volume

34

Pages

2188 - 2196

Keywords

Antibodies, HIV-1, Polyanionic carbomer, Th1 immune responses, Vaccine adjuvant, Acrylic Resins, Adaptive Immunity, Adjuvants, Immunologic, Animals, Antigen-Presenting Cells, Cell Line, Chemokines, Cytokines, Humans, Immunoglobulin G, Inflammation, Mice, 129 Strain, Mice, Inbred BALB C, Mice, Inbred C57BL, Pathogen-Associated Molecular Pattern Molecules, Phagocytosis, Th1 Cells